ロード中...
Control of the heparosan N-deacetylation leads to an improved bioengineered heparin
The production of the anticoagulant drug heparin from non-animal sources has a number of advantages over the current commercial production of heparin. These advantages include better source material availability, improved quality control, and reduced concerns about animal virus or prion impurities....
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3124281/ https://ncbi.nlm.nih.gov/pubmed/21484210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-011-3231-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|